Home/Filings/4/0001209191-24-004211
4//SEC Filing

Cataldi Fabio 4

Accession 0001209191-24-004211

CIK 0001785345other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 4:14 PM ET

Size

5.8 KB

Accession

0001209191-24-004211

Insider Transaction Report

Form 4
Period: 2024-02-29
Cataldi Fabio
Chief Medical Officer
Transactions
  • Award

    Restricted Stock Unit

    2024-02-29+21,13821,138 total
    Exp: 2034-02-28Common Stock (21,138 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents the right to receive one share of Landos Biopharma, Inc., Inc. common stock.
  • [F2]The Restricted Stock Unit ("RSU") shall vest as to 66 2/3% of the shares underlying the RSU on the second anniversary of the date of grant and shall vest as to 33 1/3% of the shares underlying the RSU on the third anniversary of the date of grant, subject to the Reporting Person's continuous service with the Issuer on each such date.

Issuer

Landos Biopharma, Inc.

CIK 0001785345

Entity typeother

Related Parties

1
  • filerCIK 0001944447

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:14 PM ET
Size
5.8 KB